Severity of Cytokine Release Syndrome Influences Outcome After Axicabtagene Ciloleucel for Large B cell Lymphoma: Results from the US Lymphoma CAR-T Consortium.
Saved in:
| Title: | Severity of Cytokine Release Syndrome Influences Outcome After Axicabtagene Ciloleucel for Large B cell Lymphoma: Results from the US Lymphoma CAR-T Consortium. |
|---|---|
| Authors: | Jacobs MT; Washington University School of Medicine and Siteman Cancer Center, St. Louis, MO., Jain MD; Moffitt Cancer Center, Tampa, FL., Gao F; Washington University School of Medicine and Siteman Cancer Center, St. Louis, MO., Nastoupil LJ; The University of Texas MD Anderson Cancer Center, Houston, TX., Spiegel JY; Stanford University Medical Center, Stanford, CA., Lin Y; Mayo Clinic, Rochester, MN., Dahiya S; University of Maryland School of Medicine and Greenebaum Comprehensive Cancer Center, Baltimore, MD., Lunning M; University of Nebraska Medical Center, Omaha, NE., Lekakis L; University of Miami Miller School of Medicine, Miami, FL., Reagan PM; University of Rochester Medical Center, Rochester, NY., Oluwole OO; Vanderbilt-Ingram Cancer Center, Nashville, TN., McGuirk J; University of Kansas Medical Center, Kansas City, KS., Deol A; Karmanos Center Institute/Wayne State University, Detroit, MI., Sehgal A; UPMC Hillman Cancer Center, Pittsburgh, PA., Goy A; John Theurer Cancer Center, Hackensack Meridian Health, Hackensack, NJ., Hill BT; Cleveland Clinic, Cleveland, OH., Andreadis C; University of CA San Francisco, San Francisco, CA., Munoz J; Banner MD Anderson Cancer Center, Gilbert, AZ., Chavez JC; Dept. of Malignant Hematology, Moffitt Cancer Center, Washington, DC., Bennani NN; Mayo Clinic, Rochester, MN., Rapoport AP; University of Maryland School of Medicine and Greenebaum Comprehensive Cancer Center, Baltimore, MD., Vose JM; University of Nebraska Medical Center, Omaha, NE., Miklos DB; Stanford University Medical Center, Stanford, CA., Neelapu SS; The University of Texas MD Anderson Cancer Center, Houston, TX., Ghobadi A; Washington University School of Medicine and Siteman Cancer Center, St. Louis, MO., Locke FL; Moffitt Cancer Center, Tampa, FL. Electronic address: Frederick.Locke@moffitt.org. |
| Source: | Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2022 Oct; Vol. 22 (10), pp. 753-759. Date of Electronic Publication: 2022 May 23. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 101525386 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2152-2669 (Electronic) Linking ISSN: 21522669 NLM ISO Abbreviation: Clin Lymphoma Myeloma Leuk Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2152-2669 |
|---|---|
| DOI: | 10.1016/j.clml.2022.05.004 |
